Align Technology Inc (ALGN): Debts to Book Capitalization

Brandmark of Invisalign (ALGN)

Align Technology, Inc. (ALGN) management protects its dominance through digitalization and patents. The company's debt relative to its book capitalization on GURU.Markets reflects leverage dynamics, where 0.03 represents the latest metric reading. The bet on AI and iTero 3D scanning helps offset the decline in consumer demand for expensive orthodontic correction and pressure from low-cost alternatives.

ALGN - Align Corp Debts to Net Assets over the range 07/04/2022 - 10/27/2026

Metric breakdowns and analytics for Invisalign (ALGN)

- price and consensus price forecast:
Stock Price Align Technology, Inc.|ALGN - Average Forecast Price
- market capitalization data:
Market Capitalization Align Corp|ALGN - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Align Technology|ALGN - Book Valuation of Business|Market Capitalization to Book Value Ratio aligntech.com|ALGN - Company Total Assets
- debt and liquidity data:
Debt to Equity Align Technology, Inc.|ALGN - Long-Term Debt to Equity|Short-Term Debt to Capital Align Technology Inc|ALGN - Company Total Debt Obligations|Debt to Book Value Align Corp
Analysis of all company metrics:Align Technology, Inc.
Original product of Invisalign

For an investor in Align Technology, Inc. (ALGN), the undisputed leader in digital orthodontics with the Invisalign system, assessing the business's financial autonomy is critical. This metric measures the share of total liabilities within the balance sheet asset structure; by analyzing the company's debt-to-equity ratio, one can confirm a decreasing dependence on creditors or identify the risk of underutilizing financial leverage.

Competitors of Align Technology, Inc.

BSX: Debts to Book Capitalization|Debts to Book Value edwards.com EW|RMD: Debts to Book Capitalization|PODD - Debt to Book Value|Zimmer Biomet - Debts to Book Capitalization|CooperSurgical (COO) - Debts to Net Assets|GMED (Globus Medical, Inc.) - Debts to Book Capitalization|Debts to Book Capitalization TMDX|Debt to Book Capitalization Ratio Alphatec (ATEC)|Debt to Book Capitalization Ratio CryoLife (AORT)|Debts to Book Capitalization ENOV|IART - Debts to Net Assets|Debt to Book Value Establishment Labs|BBNX - Debts to Book Capitalization Ratio|Debts to Book Capitalization IRMD|Embecta Corp (EMBC) - Debts to Book Value|Debts to Book Capitalization Tandem Diabetes (TNDM)|Debt to Book Value Ratio Axogen Surgical (AXGN)|SI-BONE, Inc. (SIBN) - Debt to Book Value|Debt to Net Assets Ratio OFIX (orthofix.com)|Bioventus - Debt to Book Capitalization Ratio|Debt to Book Value OrthoPediatrics Corp KIDS|TMCI (Treace Medical) - Debts to Book Capitalization|SRTA - Debts to Book Value|Debts to Book Capitalization Carlsmed Inc|rxsight.com (RXST) - Debt to Book Value Ratio|CLPT: Debts to Book Capitalization|Debts to Net Assets Stereotaxis Inc|Debts to Book Capitalization STIM (NeuroStar)|Debt to Book Value Sight Sciences Inc (SGHT)|Debts to Book Capitalization OBIO (Orchestra BioMed, Inc.)|Anika Therapeutics Inc. - Debts to Book Capitalization|NSPR - Debt to Book Capitalization Ratio|Jin Medical International (ZJYL) - Debt to Book Capitalization Ratio|Debt to Book Value vivani.com VANI|Xtant Medical (XTNT) - Debt to Net Assets Ratio|Debts to Book Capitalization NMTC (NeuroOne Medical Technologies)|Debts to Book Value MODD|MYO: Debt to Book Capitalization Ratio|Debt to Net Assets Envoy Medical Inc. COCH|Debt to Book Value VVOS (Vivos Therapeutics, Inc)|Debts to Book Capitalization enVVeno Corp NVNO|Debts to Book Capitalization SINT (SINTX Technologies)|TNON: Debts to Net Assets|Debt to Book Capitalization Ratio Lifeward (LFWD)|AMIX (Autonomix Medical) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio IVF|Debt to Book Value Bone Biologics Inc|Axonics, Inc. - Debts to Book Capitalization|Debts to Book Value BIOL (biolase.com)|DYNT - Debt to Book Capitalization Ratio|FNA - Debt to Book Value Ratio|Debt to Book Value INVO Bio INVO